Harvard Bioscience 10K Form

Sell

37

HBIO
Harvard Bioscience

Last Price:

2.82

Seasonality Move:

1.99%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-07	10Q	HBIO/Harvard Bioscience Quarterly
2023-11-07	10Q	HBIO/Harvard Bioscience Quarterly
2023-08-08	10Q	HBIO/Harvard Bioscience Quarterly
2023-04-26	10Q	HBIO/Harvard Bioscience Quarterly
2022-11-09	10Q	HBIO/Harvard Bioscience Quarterly
2022-08-04	10Q	HBIO/Harvard Bioscience Quarterly

Receive HBIO News And Ratings

See the #1 stock for the next 7 days that we like better than HBIO

HBIO Financial Statistics

Sales & Book Value

Annual Sales:	$112.25M
Cash Flow:	$683K
Price / Cash Flow:	11.35
Annual Sales:	$1.58
Price / Book:	1.81

Profitability

EPS (TTM):	-0.20000
Net Income (TTM):	$-8.73M
Gross Margin:	$66.07M
Return on Equity:	-11.93%
Return on Assets:	-6.25%

Harvard Bioscience Earnings Forecast

Key Harvard Bioscience Financial Ratios

The Gross Profit Margin over the past 26 years for HBIO is 58.86%.
The Selling, General & Administrative Expenses for HBIO have been equal to 41.77% of Gross Profit Margin.
The Research & Development expenses have been 10.48% of Revenue.
The Interest Expense is -105.15% of Operating Income.
The Net Earning history of HBIO is -3.04% of Total Revenues.
Per Share Earnings over the last 26 years have been positive in 13 years.

Harvard Bioscience Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Current Symbol:	HBIO
CUSIP:	416906
Website:	harvardbioscience.com

Debt

Debt-to-Equity Ratio:	0.52
Current Ratio:	1.88
Quick Ratio:	0.76

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	10.07

HBIO Technical Analysis vs Fundamental Analysis

Sell

37

Harvard Bioscience (HBIO) is a Sell

Is Harvard Bioscience a Buy or a Sell?

Harvard Bioscience stock is rated a Sell
The current Harvard Bioscience [HBIO] share price is $2.87. The Score for HBIO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.